This focused issue on “Anticoagulant and Antithrombotic Therapy: Globally Applied According to Local Geographical Selection Criteria” is edited by Prof. Emmanuel J Favaloro, Institute of Clinical Pathology & Medical Research, Westmead Hospital, NSW, Australia.
Prof. Emmanuel J Favaloro is a Principal Hospital Scientist, in charge of the Haemostasis laboratories at the Institute of Clinical Pathology and Medical Research (ICPMR), located at Westmead Hospital, the largest public tertiary level university teaching hospital in Australia. Prof. Favaloro has co-authored over 450 papers and is the current Editor-in-Chief of Seminars in Thrombosis & Hemostasis, and a member of the editorial/advisory boards of seven other international journals. His primary interest is laboratory testing and diagnosis related to bleeding and thrombosis, particularly in developing and evaluating new or improved diagnostics.
Focused issue outline:
- Oral anticoagulants around the world: an updated state-of-the art analysis
- Anticoagulation therapy in Australia
- Anticoagulation therapy in Italy
- Anticoagulation therapy in Slovakia
- Antiplatelet agents for Sticky Platelet Syndrome
- Anticoagulation therapy in Belgium
- Anticoagulation therapy in Germany
- Anticoagulation therapy in France
- Anticoagulant therapy in Iran
- Anticoagulation therapy in Uruguay/Latin America
- Anticoagulation therapy in the United Kingdom
- Anticoagulation therapy in Nordic Countries
- Anticoagulation therapy in Argentina
The series “Anticoagulant and Antithrombotic Therapy: Globally Applied According to Local Geographical Selection Criteria” was commissioned by the editorial office, Annals of Blood without any sponsorship or funding. Emmanuel J Favaloro is serving as the unpaid Guest Editor for the series.